1. Home
  2. LEGN vs AES Comparison

LEGN vs AES Comparison

Compare LEGN & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • AES
  • Stock Information
  • Founded
  • LEGN 2014
  • AES 1981
  • Country
  • LEGN United States
  • AES United States
  • Employees
  • LEGN N/A
  • AES N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • AES Electric Utilities: Central
  • Sector
  • LEGN Health Care
  • AES Utilities
  • Exchange
  • LEGN Nasdaq
  • AES Nasdaq
  • Market Cap
  • LEGN 7.0B
  • AES 7.1B
  • IPO Year
  • LEGN 2020
  • AES 1991
  • Fundamental
  • Price
  • LEGN $31.78
  • AES $11.13
  • Analyst Decision
  • LEGN Strong Buy
  • AES Buy
  • Analyst Count
  • LEGN 13
  • AES 8
  • Target Price
  • LEGN $79.42
  • AES $14.63
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • AES 13.8M
  • Earning Date
  • LEGN 05-13-2025
  • AES 05-01-2025
  • Dividend Yield
  • LEGN N/A
  • AES 6.33%
  • EPS Growth
  • LEGN N/A
  • AES 146.43
  • EPS
  • LEGN N/A
  • AES 1.83
  • Revenue
  • LEGN $627,241,000.00
  • AES $12,119,000,000.00
  • Revenue This Year
  • LEGN $65.96
  • AES $4.98
  • Revenue Next Year
  • LEGN $52.55
  • AES $2.40
  • P/E Ratio
  • LEGN N/A
  • AES $6.06
  • Revenue Growth
  • LEGN 119.97
  • AES N/A
  • 52 Week Low
  • LEGN $29.27
  • AES $9.57
  • 52 Week High
  • LEGN $60.87
  • AES $22.21
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.49
  • AES 57.92
  • Support Level
  • LEGN $30.25
  • AES $10.19
  • Resistance Level
  • LEGN $35.81
  • AES $10.60
  • Average True Range (ATR)
  • LEGN 1.45
  • AES 0.36
  • MACD
  • LEGN -0.18
  • AES 0.16
  • Stochastic Oscillator
  • LEGN 27.58
  • AES 91.70

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About AES The AES Corporation

AES is a global power company that operates in 15 countries. Its generation portfolio as of year-end 2023 totals over 35 gigawatts, including renewable energy (53%), gas (27%), coal (18%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.

Share on Social Networks: